Our AI instantly delivers powerful, actionable diabetes insights from one of the world’s richest diabetes datasets.
dQ&A research reveals primary care challenges in adopting diabetes tech, highlighting needs for CGM training, simpler tools, and better industry support.
Our research finds Mounjaro patients report health benefits but face confusion and frustration during therapy initiation.
Our European study explores Time in Range in diabetes, comparing outcomes and differences across six countries.
Philly De Piante recently presented dQ&A data on Advances in Disease-Modifying Interventions at the Global Congress on Cardiology. Watch the video here.
We are excited to announce that the dQ&A team presented eight abstracts at the Advanced Technologies and Treatments for Diabetes (ATTD) 2023 conference.
dQ&A’s Trevor Bell publishes research in Current Diabetes Reports, offering insights into the critical role psychosocial issues play in diabetes management.
Our semi-annual study of digital health apps in diabetes, known as “DHx” (Digital Health Experience), finds broad variation in patient satisfaction.
We're proud to share Evelyn Cox’s EASD 2022 abstract revealing mental-health disparities among Europeans with diabetes by nationality, gender, and age.
